down arrow

Genpharmasec

  • Market Cap: Micro Cap
  • Industry: Trading
  • ISIN: INE861N01036
  • NSEID:
  • BSEID: 531592
INR
1.99
0.00 (0.00%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 78.22 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.991.99

52 Week

1.894.32
Valuation
Technical
Day's Volume

CASH

78.22 k (-3.20%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

29.98%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROE of 5.78%

  • The company has been able to generate a Return on Equity (avg) of 5.78% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Operating profit has grown by an annual rate 18.74% of over the last 5 years

 
3

Stock is technically in a Bearish range

4

With ROE of 4, it has a Expensive valuation with a 1.7 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Trading

stock-summary
Market cap

INR 110 Cr (Micro Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

22

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

4.03%

stock-summary
Price to Book

1.66

Revenue and Profits (1 Year):
Net Sales:
8 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-35.18%
0%
-35.18%
1 Year
-20.08%
0%
-20.08%
2 Years
-6.37%
0%
-6.37%
3 Years
-46.71%
0%
-46.71%
4 Years
-61.19%
0%
-61.19%
5 Years
-74.41%
0%
-74.41%

Genpharmasec for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
22.37%
EBIT Growth (5y)
18.74%
EBIT to Interest (avg)
0.96
Debt to EBITDA (avg)
3.26
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.98
Tax Ratio
30.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.11%
ROE (avg)
5.78%
Valuation key factors
Factor
Value
P/E Ratio
41
Industry P/E
22
Price to Book Value
1.66
EV to EBIT
72.89
EV to EBITDA
68.79
EV to Capital Employed
1.67
EV to Sales
3.72
PEG Ratio
0.43
Dividend Yield
NA
ROCE (Latest)
0.91%
ROE (Latest)
4.03%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sneha Sadhwani (16.8%)

Highest Public shareholder

Yogeshkumar Rasiklal Sanghavi (7.07%)

Individual Investors Holdings

59.62%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 44.54% vs 8.87% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 13.00% vs 69.49% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.34",
          "val2": "5.77",
          "chgp": "44.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.97",
          "val2": "0.25",
          "chgp": "288.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.11",
          "val2": "0.04",
          "chgp": "175.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.13",
          "val2": "1.00",
          "chgp": "13.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.63%",
          "val2": "4.33%",
          "chgp": "7.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -19.90% vs 7.21% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 5,200.00% vs 120.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.07",
          "val2": "13.82",
          "chgp": "-19.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.49",
          "val2": "-0.02",
          "chgp": "2,550.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.11",
          "val2": "0.13",
          "chgp": "-15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.59",
          "val2": "0.03",
          "chgp": "5,200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.43%",
          "val2": "-0.14%",
          "chgp": "4.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -3.91% vs 4.66% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2,922.22% vs 0.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.41",
          "val2": "20.20",
          "chgp": "-3.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.46",
          "val2": "-0.01",
          "chgp": "14,700.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.22",
          "val2": "0.25",
          "chgp": "-12.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.72",
          "val2": "0.09",
          "chgp": "2,922.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.52%",
          "val2": "-0.05%",
          "chgp": "7.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 19.16% vs -6.59% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -95.54% vs 633.33% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.41",
          "val2": "25.52",
          "chgp": "19.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.17",
          "val2": "0.26",
          "chgp": "-34.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.39",
          "val2": "0.06",
          "chgp": "550.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.05",
          "val2": "1.12",
          "chgp": "-95.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.56%",
          "val2": "1.02%",
          "chgp": "-0.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
8.34
5.77
44.54%
Operating Profit (PBDIT) excl Other Income
0.97
0.25
288.00%
Interest
0.11
0.04
175.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.13
1.00
13.00%
Operating Profit Margin (Excl OI)
11.63%
4.33%
7.30%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 44.54% vs 8.87% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 13.00% vs 69.49% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
11.07
13.82
-19.90%
Operating Profit (PBDIT) excl Other Income
0.49
-0.02
2,550.00%
Interest
0.11
0.13
-15.38%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.59
0.03
5,200.00%
Operating Profit Margin (Excl OI)
4.43%
-0.14%
4.57%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -19.90% vs 7.21% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 5,200.00% vs 120.00% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
19.41
20.20
-3.91%
Operating Profit (PBDIT) excl Other Income
1.46
-0.01
14,700.00%
Interest
0.22
0.25
-12.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.72
0.09
2,922.22%
Operating Profit Margin (Excl OI)
7.52%
-0.05%
7.57%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -3.91% vs 4.66% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 2,922.22% vs 0.00% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
30.41
25.52
19.16%
Operating Profit (PBDIT) excl Other Income
0.17
0.26
-34.62%
Interest
0.39
0.06
550.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.05
1.12
-95.54%
Operating Profit Margin (Excl OI)
0.56%
1.02%
-0.46%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 19.16% vs -6.59% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -95.54% vs 633.33% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Genpharmasec Ltd stock-summary
stock-summary
Genpharmasec Ltd
Micro Cap
Trading
Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as "Adi Rasayan Limited". The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from "Adi Rayasan Limited" to "Genpharmasec Limited" on 27th November, 2018.
Company Coordinates stock-summary
Company Details
Office 104 & 105 1st Flr, Gundecha Indl Kandivali (East) Mumbai Maharashtra : 400101
stock-summary
Tel:
stock-summary
http://www.genpharmasec.com
stock-summary
genericpharmasec09@gmail.com
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."